Article
Production of a novel influenza vaccine using insect cells: protection against drifted strains
1 Jan 2007
Abstract excerpt
A recombinant trivalent hemagglutinin (HA) vaccine produced in cell culture using the baculovirus expression system provides an attractive alternative to the current egg-based influenza vaccine (Trivalent Inactivated Influenza Vaccine [TIV]) manufacturing process. The HA genes from the annual World Health Organization-recommended strains are cloned, expressed, and purified using a general purification process....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
